Preclinical studies indicate that the kisspeptin-10 plasma half-life is approximately 4 to 10 minutes due to rapid enzymatic degradation by circulating endopeptidases. For reliable experimental reproducibility, PX1 Research provides high-purity Kisspeptin-10 manufactured in the USA, supported by lot-specific third-party HPLC/MS and endotoxin COAs, with same-day shipping from California and Arizona for orders placed before cutoff.
Preclinical studies indicate that the kisspeptin-10 plasma half-life is approximately 4 to 10 minutes due to rapid enzymatic degradation by circulating endopeptidases. For reliable experimental reproducibility, PX1 Research provides high-purity Kisspeptin-10 manufactured in the USA, supported by lot-specific third-party HPLC/MS and endotoxin COAs, with same-day shipping from California and Arizona for orders placed before cutoff.
In animal models and isolated plasma assays, Kisspeptin-10 exhibits a short terminal elimination half-life ranging from 4 to 10 minutes. This rapid clearance is driven by ubiquitous proteolytic enzymes, primarily neutral endopeptidase (NEP / CD10) and prolyl endopeptidase, which cleavage peptide bonds near the active C-terminal domain.
Because of its swift enzymatic inactivation, researchers evaluating the hypothalamic-pituitary-gonadal (HPG) axis frequently utilize continuous infusion protocols or structural stabilization strategies during in vitro and in vivo assays. Ensuring precise analytical control starts with pristine, fully characterized peptide sequences.
When designing reproductive endocrinology trials, sourcing sequence-validated reagents is vital. Researchers can order 10 mg vials of Kisspeptin-10 directly from PX1 Research to guarantee sequence accuracy, high chromatographic purity, and consistent lot-to-lot kinetics.
Kisspeptin-10 is an endogenous decapeptide corresponding to residues 112–121 of the KISS1 precursor protein (Kisspeptin-54). Despite its truncated sequence (YNWNSFGLRF-NH2), Kisspeptin-10 retains full biological potency at the KISS1 receptor (KISS1R, formerly known as GPR54), acting as a primary upstream driver of gonadotropin-releasing hormone (GnRH) secretion.
In hypothalamic research models, Kisspeptin-10 activation of KISS1R triggers intracellular phosphoinositide hydrolysis, calcium mobilization, and downstream activation of the MAP kinase pathway. This cascade stimulates the pulsatile release of GnRH, which subsequently modulates luteinizing hormone (LH) and follicle-stimulating hormone (FSH) secretion from the anterior pituitary gland.
To explore complementary pathways in neuroendocrine and pituitary research, laboratories frequently cross-reference data from our neuroendocrine research peptides catalog and explore referenced studies in the PX1 Research peptide library.
The kisspeptin-10 plasma half-life presents a distinct experimental variable in pharmacokinetic studies. Upon systemic administration or incubation in biological fluids, the decapeptide is rapidly targeted by plasma proteases. Mass spectrometry profiling reveals that cleavage primarily occurs between the Gly-Leu and Phe-Leu bonds near the amidated C-terminus, rendered non-functional once the active signaling pharmacophore is disrupted.
In rodent and ovine model systems, intravenous bolus administration yields a biphasic elimination curve. The initial distribution phase ($\alpha$-half-life) occurs within 1 to 2 minutes, followed by a terminal elimination phase ($\beta$-half-life) of 4 to 10 minutes. This short duration of action necessitates careful timing during blood sampling for downstream hormone assays.
Because non-enzymatic degradation can further compound loss of active peptide in laboratory settings, researchers must utilize high-purity material with confirmed identity. Reviewing analytical verification reports for each lot ensures that structural degradation during storage or reconstitution does not skew baseline kinetic calculations.
While Kisspeptin-10 contains the minimum active sequence required for full KISS1R activation, full-length Kisspeptin-54 displays markedly different pharmacokinetics in live model systems. The additional 44 amino acids on the N-terminal end of Kisspeptin-54 provide steric hindrance against specific circulating peptidases, extending its plasma half-life to approximately 27 to 90 minutes depending on the species studied.
However, the synthesis and purification of Kisspeptin-10 offers distinct analytical advantages in screening protocols. Its smaller molecular weight (1302.45 g/mol) allows for high-yield, highly pure solid-phase peptide synthesis (SPPS), precise mass spectrometry verification, and rapid cellular internalisation in in vitro receptor binding assays.
For comparative studies examining upstream HPG axis signaling or neuroendocrine receptor desensitization, labs often pair Kisspeptin-10 with other hypothalamic research tools like Triptorelin or Sermorelin to evaluate downstream receptor responses under controlled clearance rates.
To accommodate the brief kisspeptin-10 plasma half-life in laboratory experiments, investigators employ specific methodological approaches to preserve baseline peptide concentrations:
1. Continuous Micro-Infusion: Utilizing osmotic minipumps or automated syringe drivers to maintain steady-state plasma concentrations during extended rodent paradigms.
2. Protease Inhibitor Cocktails: Adding specific endopeptidase inhibitors (such as thiorphan for NEP inhibition) to blood collection tubes or in vitro incubation media to prevent ex vivo degradation prior to assaying.
3. Serum-Free Cell Culture Systems: Performing receptor binding and second-messenger signal transduction experiments in serum-starved media to avoid rapid cleavage by bovine or rodent serum enzymes.
4. Aliquot Cold-Chain Handling: Immediate snap-freezing of plasma samples on dry ice or liquid nitrogen to arrest enzymatic cleavage prior to RP-HPLC or ELISA quantification.
Maximizing the stability of lyophilized Kisspeptin-10 begins at the reconstitution stage. The peptide is supplied as a sterile, lyophilized trifluoroacetate (TFA) salt. Reconstitution should be performed using sterile, bacteriostatic water or sterile 0.9% sodium chloride solution for injection. For delicate in vitro receptor assays where benzyl alcohol is contraindicated, sterile deionized water or phosphate-buffered saline (PBS, pH 7.4) is recommended.
Avoid vigorous vortexing upon reconstitution, as shear stress can cause peptide aggregation. Instead, gently swirl the vial until the cake is fully dissolved. To prevent repeated freeze-thaw cycles—which accelerate physical peptide degradation and clipping—reconstituted solutions should be immediately aliquoted into single-use polypropylene microcentrifuge tubes.
Stock solutions stored at -20°C remain stable for several months, while deep-freeze storage at -80°C protects sample integrity for extended research timelines. Lyophilized vials should be stored in a dry, desiccated environment at -20°C prior to reconstitution. Researchers looking to supply high-volume screening protocols can explore bulk procurement options for consistent single-lot sourcing.
Inconsistent peptide purity or residual synthetic impurities (such as truncated sequences or TFA salts) can dramatically skew kinetic calculations and enzymatic degradation assays. When sourcing materials for pharmacokinetic research, vetting vendor credentials is a vital step.
Red flags in peptide procurement include missing lot-specific COAs, vague purity claims ('99% theoretical purity' without HPLC chromatograms), absence of mass spectrometry data, and suppliers operating without verified domestic laboratory facilities. Truncated peptide fragments or residual heavy metal catalysts can act as biological artifacts, confounding receptor binding data.
To protect trial integrity, verify that every batch includes an independent third-party certificate of analysis demonstrating purity via Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) and sequence verification via Electrospray Ionization Mass Spectrometry (ESI-MS).
When establishing standardized laboratory procurement, evaluate vendors using the objective criteria outlined below:
- Purity Verification: Every lot must undergo analytical RP-HPLC to confirm peptide purity $\ge 98\%$.
- Molecular Mass Confirmation: High-resolution ESI-MS or MALDI-TOF data confirming correct monoisotopic mass without sequence truncation.
- Endotoxin Testing: Quantitative Chromogenic LAL assay verifying endotoxin levels $<0.05$ EU/mg, preventing premature immune cell activation in tissue cultures.
- Sourcing & Synthesis: Domestic USA-based synthesis and purification under rigid quality management systems.
- Traceability: Direct matching between vial lot numbers and publicly accessible third-party COAs.
- Shipping Speed: Temperature-controlled or expedited transit from local fulfillment hubs (e.g., California and Arizona) to minimize environmental exposure.
PX1 Research strictly adheres to all six benchmark standards, ensuring your experimental models produce consistent, replicable half-life and potency data.
When your laboratory demands absolute sequence integrity and reliable kinetics, PX1 Research provides fully documented, research-grade compounds. Each vial of Kisspeptin-10 contains 10 mg of lyophilized decapeptide, synthesized under stringent solid-phase protocols in the United States.
Orders placed before cutoff Monday through Friday dispatch same-day from our dual fulfillment centers in California and Arizona via tracked domestic shipping services. Every shipment is backed by verified, batch-specific COAs accessible online, detailing exact chromatographic purity, mass spectrometry profiles, and endotoxin metrics.
Streamline your laboratory's neuroendocrine workflow today: buy lyophilized Kisspeptin-10 directly from PX1 Research, or explore our full catalog of research compounds at /all-peptides.
What is the plasma half-life of kisspeptin-10?
In preclinical animal models, the kisspeptin-10 plasma half-life is approximately 4 to 10 minutes. This rapid clearance is primarily due to systemic proteolytic cleavage by circulating endopeptidases such as neutral endopeptidase (NEP).
Why is kisspeptin-10 plasma half-life so short in preclinical models?
Kisspeptin-10 is a decapeptide lacking the protective N-terminal domain found in Kisspeptin-54. Circulating peptidases rapidly target and cleave peptide bonds near its C-terminus, resulting in rapid clearance and a short physiological half-life.
How does kisspeptin-10 compare to kisspeptin-54 in stability?
Kisspeptin-54 has a longer plasma half-life (27 to 90 minutes) due to N-terminal steric protection against endopeptidases. Kisspeptin-10 has a shorter half-life (4 to 10 minutes) but offers superior synthesis purity and rapid kinetic action for in vitro assays.
What enzymes degrade kisspeptin-10 in blood plasma?
The primary enzymes responsible for kisspeptin-10 degradation are neutral endopeptidase (NEP / CD10), prolyl endopeptidase, and various circulating carboxypeptidases that cleave the C-terminal signaling region.
How should kisspeptin-10 be stored to prevent degradation?
Lyophilized Kisspeptin-10 should be stored at -20°C in a dry, desiccated environment. Once reconstituted, aliquot into single-use tubes and store at -20°C or -80°C to prevent degradation from freeze-thaw cycles.
Is kisspeptin-10 available with third-party analytical testing?
Yes. PX1 Research provides batch-specific third-party Certificates of Analysis (COAs) for every lot of Kisspeptin-10, confirming $\ge 98\%$ RP-HPLC purity, mass spectrometry sequence match, and endotoxin levels.
What solvent is recommended for reconstituting kisspeptin-10?
For standard laboratory procedures, reconstitute Kisspeptin-10 using sterile bacteriostatic water, sterile 0.9% saline, or sterile deionized water. Gently swirl without vortexing to ensure full dissolution.
How fast does PX1 Research ship kisspeptin-10 orders?
Orders placed before cutoff Monday through Friday ship same-day from fulfillment facilities located in California and Arizona, utilizing fast, tracked domestic transit.
Does PX1 Research provide endotoxin testing on kisspeptin-10 lots?
Yes. Every lot of Kisspeptin-10 undergo quantitative Chromogenic LAL testing to verify endotoxin levels are below 0.05 EU/mg, preventing cellular toxicity during in vitro experiments.
Can kisspeptin-10 be purchased in bulk for high-throughput screening?
Yes. PX1 Research supports large-scale academic and industrial research through our wholesale program. Visit our bulk ordering page to submit a request for high-volume single-lot procurement.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.